Treatment
|
Catalase activitya
|
GPx activityb
|
GR activityb
|
---|
|
Brain
|
Liver
|
Brain
|
Liver
|
Brain
|
Liver
|
---|
PBS/DMSO
|
0.55 ± 0.04
|
4.44 ± 0.7
|
8.12 ± 0.6
|
93.0 ± 3.6
|
21.05 ± 0.1
|
38.6 ± 4.3
|
NAC/DMSO
|
0.66 ± 0.1
|
5.19 ± 0.8
|
9.09 ± 0.6
|
105.1 ± 9.2
|
25.58 ± 2.55
|
45.6 ± 3.9
|
PBS/TeAsp
|
0.57 ± 0.05
|
3.72 ± 0.5
|
8.47 ± 0.4
|
91.8 ± 2.5
|
18.94 ± 0.65
|
44.8 ± 5.1
|
NAC/TeAsp
|
0.64 ± 0.1
|
3.38 ± 0.32
|
7.06 ± 0.65
|
97.1 ± 7.2
|
19.862.0
|
62.5 ± 5.9*
|
- Results are mean ± S.E.M., n= 5 per group. One way ANOVA followed by Newman-Keuls Multiple Comparison Test.
- *Values significantly different from the PBS/DMSO group with p<0.05.
- aCatalase activity is expressed as μmol H2O2/min/mg of protein.
- bGPx activity and GR activity are expressed as nmol NADPH/min/mg of protein.